Co-Diagnostics, Inc.  ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoSara ...

Visby Medical, a leading innovator in at-home PCR testing of infectious diseases, has announced a strategic collaboration ...

Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...

Each year, tens of thousands of serious homebuyers begin their relocation journey on PrivateCommunities.com. With nearly 1 million annual visitors and a highly engaged audience of buyers aged 45–65+, ...

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or ...

The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...

The fusion of biophotonics and AI is transforming healthcare, enhancing diagnostics and treatment with advanced light-based ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

BISC is an ultra-thin neural implant that creates a high-bandwidth wireless link between the brain and computers. Its tiny single-chip design packs tens of thousands of electrodes and supports ...

The world’s first paper-like display capable of true real-time, full-colour, full-motion performance, reaching 75Hz at 5ms response time with True 8-bit colour reproduction is coming to market.

If proven to be accurate, the point-of-care test could provide the NHS with a highly scalable, low-cost diagnostic tool. It ...

Public health recommendations suggest individuals can resume normal activities 5 days after symptom cessation. However, our study finds that full recovery can take longer, indicating that delayed ...